Medicine for transnasal administration

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/165 (2006.01) A61K 9/08 (2006.01) A61K 9/10 (2006.01) A61K 9/107 (2006.01) A61K 9/12 (2006.01) A61K 9/14 (2006.01) A61K 45/00 (2006.01) A61K 47/14 (2006.01) A61K 47/18 (2006.01) A61P 25/24 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2640451

The invention provides for an SNRI-containing preparation which has a higher absorbability compared to a conventional SNRI preparation, can produce its effect rapidly, and can be readily administered to a patient who is hard to be administered via an oral route. Disclosed is an SNRI-containing preparation for transmucosal administration or transdermal administration.

L'invention concerne une préparation contenant un SNRI qui possède une plus haute absorbabilité qu'une préparation conventionnelle de SNRI, qui peut produire son effet rapidement, et qui peut être administrée aisément à un patient pour qui une administration par voie orale est difficile. L~invention concerne une préparation contenant un SNRI pour administration transmucosale ou transdermique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicine for transnasal administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicine for transnasal administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicine for transnasal administration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1671857

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.